Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Arbutus Biopharma Corp

NASDAQ: ABUS · Life Sciences · 4 alerts · CIK 1447028

Share price
$4.04Close, Nov 16
Market cap
$619M
Shares outstanding
153.29MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Arbutus Biopharma Corp filings on SEC EDGAR ↗

7:31 AM ET 8-K
Business Update

Arbutus Biopharma Business Update

Arbutus Biopharma announced that the FDA has lifted the clinical hold on the Investigational New Drug (IND) application for AB-101, its oral PD-L1 inhibitor. The company is now authorized to resume clinical development of the candidate in the United States and is evaluating next steps for its continued development. AB-101 is being developed as a potential treatment for chronic hepatitis B virus (cHBV) infection.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.